In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
no speaker photo
Speaker
Silvia Rollefstad
Silvia Rollefstad Silvia Rollefstad

Diakonhjemmet Hospital, Oslo (Norway)

Speciality : Rehabilitation and Sports Cardiology

5 presentations from this speaker

Effects of statin treatment on coronary plaques in patients with inflammatory joint diseases

Event : ESC Congress 2018

  • Session : Cardiovascular disease in the elderly, autoimmune / chronic inflammatory disorders
  • Speaker : S Rollefstad (Oslo,NO)

Cardiovascular preventive medication and achievement of treatment targets in patients with osteoarthritis: Results from the MUST-Heart study

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2015

  • Session : Prevention, Epidemiology & Population Science
  • Speaker : S Rollefstad (Oslo,NO)

Risk of cardiovascular disease in patients with osteoarthritis: Results from the MUST-Heart study

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2015

  • Session : Prevention, Epidemiology & Population Science
  • Speaker : S Rollefstad (Oslo,NO)

Rosuvastatin induced carotid plaque regression in patients with inflammatory joint diseases: The RORA-AS study

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2015

  • Session : Prevention, Epidemiology & Population Science
  • Speaker : S Rollefstad (Oslo,NO)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are